Publication Venue For

  • Prognostic Impact of Tumor Size on Pancreatic Neuroendocrine Tumor Recurrence May Have Racial Variance.  50:347-352. 2021
  • Acute Pancreatitis from Treatment with BRAF Inhibitors in Erdheim-Chester Disease: A Report from 2 Tertiary Referral Centers.  50:e6-e8. 2021
  • Sp H incterotomy for A cute R ecurrent P ancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications.  48:1061-1067. 2019
  • The Clinicopathological Aspects of Primary Presacral Neuroendocrine Neoplasms: One Center Experience.  47:122-129. 2018
  • Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort.  45:934-940. 2016
  • Primary and liver metastasis-derived cell lines from Kras G12D; Trp53 R172H; Pdx-1 cre animals undergo apoptosis in response to triptolide.  44:583-589. 2015
  • Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout mice.  43:143-145. 2014
  • Consensus guidelines for the management and treatment of neuroendocrine tumors.  42:557-577. 2013
  • Ratio of pancreatic duct caliber to width of pancreatic gland by endosonography is predictive of pancreatic cancer.  42:670-679. 2013
  • Mixed acinar-endocrine carcinoma of the pancreas: New clinical and pathological features in a contemporary series.  42:429-435. 2013
  • A deimmunized bispecific ligand-directed toxin that shows an impressive anti-pancreatic cancer effect in a systemic nude mouse orthotopic model.  41:789-796. 2012
  • A new drug delivery method of bispecific ligand-directed toxins, which reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer.  39:913-922. 2010
  • The north american neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancer.  39:775-783. 2010
  • Homozygous p86s mutation of the human glucagon receptor is associated with hyperglucagonemia, α cell hyperplasia, and islet cell tumor.  38:941-946. 2009
  • Cost minimization analysis comparing diagnostic strategies in unexplained pancreatitis.  38:117-121. 2009
  • The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.  37:19-24. 2008
  • Nesidioblastosis and hyperplasia of α cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: Review of the literature.  36:428-431. 2008
  • Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059.  25:251-259. 2002
  • Organized pancreatic necrosis: Endoscopic, radiologic, and pathologic features of a distinct clinical entity.  19:105-108. 1999
  • International Standard Serial Number (issn)

  • 0885-3177
  • Electronic International Standard Serial Number (eissn)

  • 1536-4828